Upload Avatar (500 x 500)
Ying Chen
yingchen71@fudan.edu.cn
Chinese, English
Shanghai
Fudan University
Pharmaceutical Sciences
  • 1990.09 – 1994.06 Bachelor: Shanghai Medical University, School of Pharmacy, Major in Medicinal Chemistry
  • 1995.09 – 2000.12 PhD: Shanghai Medical University, School of Pharmacy, Major in Medicinal Chemistry
  • 1994.07 – 1999.05 Shanghai Medical University, School of Pharmacy, Teaching Assistant
  • 1999.06 – 2002.11 Shanghai Medical University, School of Pharmacy, Lecturer
  • 2002.12 – 2015.11 Fudan University, School of Pharmacy, Associate Professor
  • 2008.09 – 2009.08 University of North Carolina, School of Pharmacy, Visiting Scholar
  • 2010 – 2019 Chief of the 'Medicinal Chemistry' Teaching Team; Responsible for 'Medicinal Chemistry' courses at the university and Shanghai city level
  • 2015.12 – Present Fudan University, School of Pharmacy, Professor
  • 2011 Outstanding Communist Party Member of the College
  • 2012 Advanced Individual in Undergraduate Teaching of the College
  • 2010-2013 Outstanding Union Activist in Shanghai Education System
  • 2013-2014 Fudan University 'March 8th' Red Flag Bearer
  • 2015-2017 Outstanding Faculty Representative in Shanghai Education System
Discovery of small molecule drugs for cancer treatment
Development and utilization of natural sterol resources
  • Design, synthesis and biological evaluation of seco-DSP/DCK derivatives reversing P-glycoprotein-mediated paclitaxel resistance in A2780/T cells, Weijie Wang, Qi Wan, Mengru Li, Feng Qu, Hongrui Liu, Ying Chen, 2023
  • Novel Hybrids of 3-Substituted Coumarin and Phenylsulfonylfuroxan as Potent Antitumor Agents with Collateral Sensitivity against MCF-7/ADR, Zhihui Yu, Mengru Li, Ke Wang, Yuting Gu, Shiqi Guo, Weijie Wang, Yulei Ma, Hongrui Liu, Ying Chen, 2022
  • New Seco-DSP Derivatives as Potent Chemosensitizers, Qi Wan, Xin Jin, Yalan Guo, Zhihui Yu, Shiqi Guo, Susan Morris-Natschke, Kuo-Hsiung Lee, Hongrui Liu, Ying Chen, 2020
  • Synthesis and Antitumor Evaluation of Novel Hybrids of Phenylsulfonylfuroxan and Estradiol Derivatives, Qi Wan, Yan Deng, Yaoqing Huang, Zhihui Yu, Chunli Wang, Ke Wang, Jibin Dong, Ying Chen, 2020
  • Seco-4-methyl-DCK derivatives as potent chemosensitizers, Yalan Guo, Ke Wang, Xiaoyu Chen, Haihong Li, Qi Wan, Susan Morris-Natschke, Kuo-Hsiung Lee, Ying Chen, 2019
  • Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives, Haihong Li, Ke Wang, Qi Wan, Ying Chen, 2019
  • Novel Nitric Oxide Donors of Phenylsulfonylfuroxan and 3-Benzyl Coumarin Derivatives as Potent Antitumor Agents, Yalan Guo, Yujie Wang, Haihong Li, Ke Wang, Qi Wan, Jia Li, Yubo Zhou, Ying Chen, 2018
  • Steroids, Yaoqing Huang, Mingming Liu, Lanfang Meng, Pan Feng, Yalan Guo, Minghua Ying, Xiuyan Zhu, Ying Chen, 2015
  • Hybrids of Phenylsulfonylfuroxan and Coumarin as Potent Antitumor Agents, Ming-Ming Liu, Xiao-Yu Chen, Yao-Qing Huang, Pan Feng, Ya-Lan Guo, Gong Yang, Ying Chen, 2014
  • European Journal of Medicinal Chemistry, Ying Chen, Hong-Rui Liu, Hong-Shan Liu, Ming Cheng, Peng Xia, Keduo Qian, Pei-Chi Wu, Chin-Yu Lai, Yi Xia, Zheng-Yu Yang, Susan L. Morris-Natschke, Kuo-Hsiung Lee, 2012
Cancer Treatment Small Molecule Drugs Drug Discovery Medicinal Chemistry Natural Products Sterols Pharmacology Biochemistry Oncology Therapeutics

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.